BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24952599)

  • 1. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
    Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
    Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.
    Medapati MR; Dahlmann M; Ghavami S; Pathak KA; Lucman L; Klonisch T; Hoang-Vu C; Stein U; Hombach-Klonisch S
    Thyroid; 2015 May; 25(5):514-27. PubMed ID: 25744544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.
    Grotterød I; Maelandsmo GM; Boye K
    BMC Cancer; 2010 May; 10():241. PubMed ID: 20507646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.
    Herwig N; Belter B; Wolf S; Haase-Kohn C; Pietzsch J
    J Cell Mol Med; 2016 May; 20(5):825-35. PubMed ID: 26928771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products.
    Yammani RR; Carlson CS; Bresnick AR; Loeser RF
    Arthritis Rheum; 2006 Sep; 54(9):2901-11. PubMed ID: 16948116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.
    Dahlmann M; Sack U; Herrmann P; Lemm M; Fichtner I; Schlag PM; Stein U
    Oncotarget; 2012 Aug; 3(8):783-97. PubMed ID: 22878175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4.
    Spiekerkoetter E; Guignabert C; de Jesus Perez V; Alastalo TP; Powers JM; Wang L; Lawrie A; Ambartsumian N; Schmidt AM; Berryman M; Ashley RH; Rabinovitch M
    Circ Res; 2009 Sep; 105(7):639-47, 13 p following 647. PubMed ID: 19713532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A4 is secreted by airway smooth muscle tissues and activates inflammatory signaling pathways via receptors for advanced glycation end products.
    Wu Y; Zhang W; Gunst SJ
    Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L185-L195. PubMed ID: 32432920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
    Boye K; Nesland JM; Sandstad B; Haugland Haugen M; Mælandsmo GM; Flatmark K
    Br J Cancer; 2012 Aug; 107(4):667-74. PubMed ID: 22782346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.
    Huang LY; Xu Y; Cai GX; Guan ZQ; Sheng WQ; Lu HF; Xie LQ; Lu HJ; Cai SJ
    World J Gastroenterol; 2011 Jan; 17(1):69-78. PubMed ID: 21218086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
    Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
    Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
    Wang XG; Meng Q; Qi FM; Yang QF
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer.
    Kim JH; Kim CN; Kim SY; Lee JS; Cho D; Kim JW; Yoon SY
    Oncol Rep; 2009 Jul; 22(1):41-7. PubMed ID: 19513503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells.
    Huang L; Xu Y; Cai G; Guan Z; Cai S
    Oncol Rep; 2012 Apr; 27(4):917-22. PubMed ID: 22200787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer.
    Flatmark K; Pedersen KB; Nesland JM; Rasmussen H; Aamodt G; Mikalsen SO; Bjørnland K; Fodstad Ø; Maelandsmo GM
    J Pathol; 2003 Aug; 200(5):589-95. PubMed ID: 12898594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer.
    Kang YG; Jung CK; Lee A; Kang WK; Oh ST; Kang CS
    J Surg Oncol; 2012 Feb; 105(2):119-24. PubMed ID: 21837681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.
    Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM
    J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.